EUVIMEDEUVIMED entdecken
Crossref

Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening

Xin Zeng iD, Yanzhen Yu, Yifan Wu, Geng Chen, Rong Sheng iD

Drug Development Research · 2026-05 · 87 (3)

DOI: 10.1002/ddr.70290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 27.04.2026. Verfasst von Xin Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinases, Protein Kinase Inhibitors, Pyrroles. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RIPK1 regulates the pathways in programmed cell death, and is closely associated with inflammatory and immune diseases. Based on the pharmacophore‐based virtual screening, compound 15 , a tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione derivative, was identified as a hit of RIPK1 inhibitor with an IC 50 value of 6.42 μM. Furthermore, a similarity searching was carried out to get more potent RIPK1 inhibitors. Among them, compound 21 showed obvious improvement in RIPK1 inhibitory activity with an IC 50 value of 2.21 μM, accompanied with moderate anti‐necroptosis activity in HT‐29 cells (IC 50 = 15.32 μM). Molecular dynamics (MD) simulations indicated that it probably functioned as a type III kinase inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor-Interacting Protein Serine-Threonine KinasesProtein Kinase InhibitorsPyrrolesHumansPharmacophoreHT29 CellsMolecular Dynamics SimulationStructure-Activity RelationshipNecroptosisDrug DiscoveryMolecular Docking Simulation

Stichwörter der Autor:innen

RIPK1 inhibitorspharmacophore modelingvirtual screening

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesRIPK1 protein, humanProtein Kinase InhibitorsPyrroles

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Jinhua Institute of Zhejiang University, Zhejiang Provincial Engineering Research Center for Innovative Small-Molecule Drugs, Jinhua, China.

ORCID-Profile: Xin Zeng, Rong Sheng

Zitieren

APA

Zeng, X., Yu, Y., Wu, Y., Chen, G., & Sheng, R. (2026). Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening. Drug Development Research, 87(3). https://doi.org/10.1002/ddr.70290

Vancouver

Zeng X, Yu Y, Wu Y, Chen G, Sheng R. Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening. Drug Development Research. 2026;87(3). doi:10.1002/ddr.70290

BibTeX
@article{Zeng2026,
  author = {Zeng, Xin and Yu, Yanzhen and Wu, Yifan and Chen, Geng and Sheng, Rong},
  title = {Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {3},
  doi = {10.1002/ddr.70290}
}
Kostenlos starten →